CLINICAL_TRIALS
research
· 2021-07-22
Clinical Trial Update: Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment [Phase 2]
Summary
A Phase 2 clinical trial exploring tailoring treatment for advanced diffuse large B-cell non-Hodgkin lymphoma based on mid-treatment PET scan results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: British Columbia Cancer Agency | Conditions: Lymphoma, Non-Hodgkin, Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma | Phase 2 | Status: UNKNOWN